Search alternatives:
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
patient decrease » point decrease (Expand Search), transient decrease (Expand Search), largest decrease (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
_ patient » _ patients (Expand Search)
Showing 1 - 20 results of 7,659 for search '(( third ((((step decrease) OR (greater decrease))) OR (a decrease)) ) OR ( _ patient decrease ))', query time: 0.49s Refine Results
  1. 1
    Third.

    Third. by Cuicui Liu (1496260)

    Published 2024
    Save to List
    Saved in:
  2. 2
    These subfigures show a visualization of the context embeddings for the DSVAE model with LS=2=4,CS=2. The first subfigure from the left shows three patient clusters, the second subfigure both patients and controls, the third colors context embeddings based on the subject’s age, and the last subfigure colors the context embeddings based on the subject’s cognitive score, CMINDs.

    These subfigures show a visualization of the context embeddings for the DSVAE model with LS=2=4,CS=2. The first subfigure from the left shows three patient clusters, the second sub... by Eloy Geenjaar (21533195)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 3
    Maximum IFN concentrations are decreased in severe patients.

    Maximum IFN concentrations are decreased in severe patients. by Sonia T. Gazeau (21512764)

    Published 2025
    Save to List
    Saved in:
  4. 4
    Flow diagram of patient selection for the study.

    Flow diagram of patient selection for the study. by Yusuke Fuchioka (22806178)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 5
    Experimental validation revealed that ACADSB and ACADM decreased in patients with UC.

    Experimental validation revealed that ACADSB and ACADM decreased in patients with UC. by Hongliang Chen (538815)

    Published 2025
    Save to List
    Saved in:
  6. 6
    Femoral trochlear 3D-MRI before and after OWHTO in all cases.

    Femoral trochlear 3D-MRI before and after OWHTO in all cases. by Yusuke Fuchioka (22806178)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 7
    Patellar 3D-MRI before and after OWHTO in all cases.

    Patellar 3D-MRI before and after OWHTO in all cases. by Yusuke Fuchioka (22806178)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 8
    Additional file 7 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study

    Additional file 7 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study by Juliane Schikora (20871169)

    Published 2025
    Save to List
    Saved in:
  9. 9
    Additional file 3 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study

    Additional file 3 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study by Juliane Schikora (20871169)

    Published 2025
    Save to List
    Saved in:
  10. 10
    Dynamic Covalent Chemistry Enabled Closed-Loop Recycling of Thermally Modified Polymer Membrane

    Dynamic Covalent Chemistry Enabled Closed-Loop Recycling of Thermally Modified Polymer Membrane by Ching Yoong Loh (17863097)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 11
    Dynamic Covalent Chemistry Enabled Closed-Loop Recycling of Thermally Modified Polymer Membrane

    Dynamic Covalent Chemistry Enabled Closed-Loop Recycling of Thermally Modified Polymer Membrane by Ching Yoong Loh (17863097)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 12
    Dynamic Covalent Chemistry Enabled Closed-Loop Recycling of Thermally Modified Polymer Membrane

    Dynamic Covalent Chemistry Enabled Closed-Loop Recycling of Thermally Modified Polymer Membrane by Ching Yoong Loh (17863097)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 13
    Dynamic Covalent Chemistry Enabled Closed-Loop Recycling of Thermally Modified Polymer Membrane

    Dynamic Covalent Chemistry Enabled Closed-Loop Recycling of Thermally Modified Polymer Membrane by Ching Yoong Loh (17863097)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 14
    Dynamic Covalent Chemistry Enabled Closed-Loop Recycling of Thermally Modified Polymer Membrane

    Dynamic Covalent Chemistry Enabled Closed-Loop Recycling of Thermally Modified Polymer Membrane by Ching Yoong Loh (17863097)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 15
    Table6_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx

    Table6_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

    Published 2024
    “…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”
    Save to List
    Saved in:
  16. 16
    Table4_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx

    Table4_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

    Published 2024
    “…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”
    Save to List
    Saved in:
  17. 17
    Table2_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx

    Table2_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

    Published 2024
    “…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”
    Save to List
    Saved in:
  18. 18
    Table8_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx

    Table8_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

    Published 2024
    “…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”
    Save to List
    Saved in:
  19. 19
    Table5_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx

    Table5_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

    Published 2024
    “…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”
    Save to List
    Saved in:
  20. 20
    Table3_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx

    Table3_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

    Published 2024
    “…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”
    Save to List
    Saved in:

Search Tools: